Skip to content
Create account to build your panelHelp me choose

DHEA-S: What It Can Tell You About Acne, PCOS, and Aging

By the EllaDx team · Updated November 5, 2026 · 9 min read

For education only, not a diagnosis. Talk to your clinician about your results.

Close-up of a woman applying lipstick in a small mirror
← Back to Journal

DHEA and its sulfated form, DHEA-S (dehydroepiandrosterone sulfate), are the most abundant circulating steroid hormones in humans (Rutkowski et al., 2014), yet DHEA-S rarely makes it into routine health conversations. Made by the adrenal glands, it can be converted into potent androgens and estrogens in other tissues (Labrie et al., 1998).

What Is DHEA-S?

DHEA-S is the sulfated form of DHEA, and the adrenal glands secrete both. Other tissues can turn these inactive precursors into androgens and estrogens according to local needs. In women, this route is a major source of estrogen: the best estimate in one review was 75% before menopause and 100% after (Labrie et al., 1998).

Key characteristics of DHEA-S:

  • Precursor hormone that can be converted into testosterone, estrogen, and other androgens (Labrie et al., 1998)
  • Adrenal marker - unlike testosterone, which comes from both the ovaries and adrenals, DHEA-S is the main marker research uses for adrenal androgen production (Goodarzi et al., 2015)
  • Changes with age - in a study of 481 women, DHEA-S peaked at ages 15-19 and then declined steadily (Orentreich et al., 1984)

DHEA-S, Stress, and the Adrenal Response

DHEA and cortisol are released together by the adrenal glands as part of the stress response (Kamin et al., 2017). Some studies link long-term stress with lower DHEA-S. Adults who reported stress at work had DHEA-S levels 23% lower on average than adults who didn't (Lennartsson et al., 2013). A burnout study found lower DHEA-S only in the youngest group, ages 25-34, and not in people aged 35-54 (Lennartsson et al., 2015). These were small studies that compared groups, so they can't show that stress depletes DHEA-S.

Researchers have studied cortisol and DHEA as a ratio because their actions can oppose each other, but the same review described major knowledge gaps (Kamin et al., 2017).

When DHEA-S Is Too High

Elevated DHEA-S in women may be associated with:

PCOS (Polycystic Ovary Syndrome)

About 20-30% of women with PCOS may have excess adrenal androgen production, measured mainly through DHEA-S (Goodarzi et al., 2015). Why this happens is still unclear, and insulin and glucose appear to play a limited role (Goodarzi et al., 2015). A study of 873 women with androgen excess found PCOS in 82% (Azziz et al., 2004). Signs of androgen excess may include:

  • Acne
  • Excess hair growth on the face, chest, or abdomen (hirsutism)
  • Thinning hair on the scalp (androgenic alopecia)
  • Irregular or absent periods
  • Difficulty conceiving

Skin and Acne

DHEA-S can be turned into more potent androgens in tissues outside the adrenal glands (Labrie et al., 1998), and DHEA has been reported to stimulate sebum production in older adults (Rutkowski et al., 2014). Experts differ on who should be tested. An androgen excess expert panel recommended measuring testosterone, free testosterone and DHEA-S in all women with adult acne, while dermatology guidance treats adult acne as an inflammatory skin disease (Carmina et al., 2022). Your clinician can help you decide if testing makes sense for you.

Congenital Adrenal Hyperplasia (CAH)

Non-classic congenital adrenal hyperplasia is an inherited condition, estimated at 1 in 1,000 to 1 in 2,000 people, that can look a lot like PCOS, with excess hair growth and ovulation or period problems (Papadakis et al., 2019). One large study found it in 1.6% of women with androgen excess (Azziz et al., 2004). A 17-hydroxyprogesterone test can help tell the two apart (Papadakis et al., 2019).

Adrenal Tumors

Rarely, an androgen-secreting tumor may be the cause. One large study found these in 0.2% of women with androgen excess (Azziz et al., 2004). A review of benign adrenal tumors found raised DHEA-S in 69% of women, and about a quarter of cases stayed below the cutoffs used to suspect a tumor, so a lab number alone can't rule one out. That review found excess hair growth and an enlarged clitoris to be the most frequent signs (García-Pérez et al., 2026). If you have a very high level or signs like these, see a clinician promptly.

When DHEA-S Is Too Low

Studies of low DHEA-S found mixed results. DHEA earned its "anti-aging" label when findings in animals were applied to people (Rutkowski et al., 2014). Here's what human studies found:

  • Long-term health: In a large study of middle-aged and older adults, both the lowest and the highest DHEA-S groups had higher death rates than the middle group (Mukama et al., 2023). This links a level with risk. It can't show that changing the level changes the risk.
  • Older women: In a two-year trial, older women with low DHEA-S who took DHEA gained bone density at the wrist, but had no gain in body composition, physical performance, insulin sensitivity or quality of life (Nair et al., 2006).
  • After menopause: A review of 23 trials found no significant effect of DHEA on libido, sexual function or bone density, with low confidence in the evidence (Elraiyah et al., 2014).
  • Steroid medicines: Low DHEA-S can accompany adrenal suppression, so it may be a clue to this side effect of steroids (Rutkowski et al., 2014).

Age-Related Decline

DHEA-S can fall steadily with age. A study of 481 women aged 11-89 found that average DHEA-S peaked at ages 15-19, at about 247 mcg/dL, and was about 45 mcg/dL above age 70, or about 80% lower (Orentreich et al., 1984). That was a snapshot of different women at different ages, not one group followed over time. One review linked this fall to some age-related changes (Labrie et al., 1998), but a decline alongside aging can't show that it causes them.

DHEA-S and Energy

DHEA is widely sold as a dietary supplement, and claims about energy are easy to find, but the trials don't settle them. Some reported better well-being in older adults, others found no benefit, and a review called for large randomized trials (Rutkowski et al., 2014) (Nair et al., 2006). Lower DHEA-S has been reported in younger adults with burnout (Lennartsson et al., 2015), but that study can't tell us whether low DHEA-S causes tiredness. If you're dealing with ongoing fatigue, a clinician can look for causes that have clear treatments.

Lab Tests That Can Help

Guidelines tie androgen testing to symptoms. The Endocrine Society suggests testing for high androgen levels in women with an abnormal hirsutism score, and suggests against it in women with regular periods who only have unwanted hair in one area (Martin et al., 2018). When testing is done, a clinician may read DHEA-S alongside:

  • Total and free testosterone - total testosterone is the first test named in a summary of that guideline (Mimoto et al., 2018)
  • SHBG - a protein that binds testosterone, which can affect how much is available
  • 17-hydroxyprogesterone - an early-morning test for women with raised testosterone or a high risk of congenital adrenal hyperplasia (Mimoto et al., 2018)
  • Prolactin and thyroid tests - for other conditions that can look like PCOS (Papadakis et al., 2019)

For adults being assessed for PCOS, AMH can be used as an alternative to an ovarian ultrasound (Teede et al., 2024). See what we test.

What You Can Do

If DHEA-S Is Elevated:

  • Work with a clinician to find out why, checking for PCOS, non-classic CAH or, rarely, a tumor
  • Mention all your medicines and supplements, including any DHEA product
  • Get checked promptly for new or fast-worsening hair growth or other new signs of androgen excess

If DHEA-S Is Low:

  • Ask your clinician what it may mean for you, taking your age into account, since DHEA-S can fall with age (Orentreich et al., 1984)
  • Tell your clinician about steroid medicines, since low DHEA-S can accompany adrenal suppression (Rutkowski et al., 2014)
  • Talk to a clinician before considering DHEA - one review concluded that larger randomized trials are needed before it enters routine care (Rutkowski et al., 2014)

References

  • Labrie, F., et al. (1998). DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids, 63(5-6), 322-328. PMID 9618795
  • Lennartsson, A. K., et al. (2015). Low levels of dehydroepiandrosterone sulfate in younger burnout patients. PLoS ONE, 10(10), e0140054. PMID 26441131
  • Goodarzi, M. O., et al. (2015). DHEA, DHEAS and PCOS. Journal of Steroid Biochemistry and Molecular Biology, 145, 213-225. PMID 25008465
  • Rutkowski, K., et al. (2014). Dehydroepiandrosterone (DHEA): hypes and hopes. Drugs, 74(11), 1195-1207. PMID 25022952
  • Elraiyah, T., et al. (2014). Clinical review: the benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function. Journal of Clinical Endocrinology & Metabolism, 99(10), 3536-3542. PMID 25279571
  • Azziz, R., et al. (2004). Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology & Metabolism, 89(2), 453-462. PMID 14764747
  • Orentreich, N., et al. (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology & Metabolism, 59(3), 551-555. PMID 6235241
  • Lennartsson, A. K., et al. (2013). Perceived stress at work is associated with lower levels of DHEA-S. PLOS One, 8(8), e72460. PMID 24015247
  • Kamin, H. S., et al. (2017). Cortisol and DHEA in development and psychopathology. Hormones and Behavior, 89, 69-85. PMID 27979632
  • Carmina, E., et al. (2022). Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. Journal of the Endocrine Society, 6(3), bvac003. PMID 35155970
  • Papadakis, G., et al. (2019). Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review. Frontiers in Endocrinology, 10, 388. PMID 31275245
  • García-Pérez, M., et al. (2026). Benign androgen-producing adrenal tumors: A systematic review of cases and case series. Endocrine, 91(1), 39. PMID 41563634
  • Mukama, T., et al. (2023). Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women-A J-shaped Relationship. Journal of Clinical Endocrinology & Metabolism, 108(6), e313-e325. PMID 36477484
  • Nair, K. S., et al. (2006). DHEA in elderly women and DHEA or testosterone in elderly men. New England Journal of Medicine, 355(16), 1647-1659. PMID 17050889
  • Martin, K. A., et al. (2018). Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 103(4), 1233-1257. PMID 29522147
  • Mimoto, M. S., et al. (2018). Evaluation and Treatment of Hirsutism in Premenopausal Women. JAMA, 319(15), 1613-1614. PMID 29522641
  • Teede, H. J., et al. (2024). Summary of the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective. Medical Journal of Australia, 221(7), 389-395. PMID 39223729